Trials / Approved For Marketing
Approved For MarketingNCT05232110
Compassionate Use of Pozelimab
- Status
- Approved For Marketing
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Regeneron Pharmaceuticals · Industry
- Sex
- —
- Age
- —
- Healthy volunteers
- —
Summary
Provide compassionate use of pozelimab
Detailed description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pozelimab |
Timeline
- First posted
- 2022-02-09
- Last updated
- 2025-11-10
Source: ClinicalTrials.gov record NCT05232110. Inclusion in this directory is not an endorsement.